Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3244)
All Articles published online
|
Dec 28, 2010 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Di Minno MND, Tufano A, Russolillo A, Di Minno G, Tarantino G. High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World J Gastroenterol 2010; 16(48): 6119-6122 [PMID: 21182227 DOI: 10.3748/wjg.v16.i48.6119] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v16/i48/6119.htm |
| Number | Citing Articles |
| 1 |
Rosario Peluso, Matteo Nicola Dario Di Minno, Salvatore Iervolino, Francesco Manguso, Giuseppina Tramontano, Pasquale Ambrosino, Carmela Esposito, Antonella Scalera, Fabiana Castiglione, Raffaele Scarpa. Enteropathic Spondyloarthritis: From Diagnosis to Treatment. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/631408
|
| 2 |
Jonathan G Stine, Curtis K Argo, Shawn J Pelletier, Daniel G Maluf, Stephen H Caldwell, Patrick G Northup. Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World Journal of Hepatology 2017; 9(3): 139-146 doi: 10.4254/wjh.v9.i3.139
|
| 3 |
Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil. The prothrombotic tendency of metabolic-associated fatty liver disease. Journal of Thrombosis and Haemostasis 2023; 21(11): 3045 doi: 10.1016/j.jtha.2023.06.017
|
| 4 |
Marion Mussbacher, Laura Brunnthaler, Anja Panhuber, Patrick Starlinger, Alice Assinger. Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases. International Journal of Molecular Sciences 2021; 22(6): 3113 doi: 10.3390/ijms22063113
|
| 5 |
Justin A Steggerda, Krishnaraj Mahendraraj, Tsuyoshi Todo, Mazen Noureddin. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. World Journal of Gastroenterology 2020; 26(28): 4018-4035 doi: 10.3748/wjg.v26.i28.4018
|
| 6 |
Ahmed Abdel-Razik, Nasser Mousa, Walaa Shabana, Ahmed H. Yassen, Mostafa Abdelsalam, Mohamed M. Wahba, Eman Mohamed Helmy, Ahmed M. Tawfik, Khaled Zalata, Ahmad S. Hasan, Rania Elhelaly, Rasha Elzehery, Aya Ahmed Fathy, Niveen El-Wakeel, Waleed Eldars. De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.650818
|
| 7 |
Tiziana Ciarambino, Pietro Crispino, Ombretta Para, Mauro Giordano. Gender Medicine: A New Possible Frontiers of Venous Thromboembolism. Stresses 2023; 3(1): 167 doi: 10.3390/stresses3010013
|
| 8 |
Aaron R. Folsom, Pamela L. Lutsey, Nicholas S. Roetker, Wayne D. Rosamond, Mariana Lazo, Susan R. Heckbert, Saonli Basu, Mary Cushman, Elizabeth Selvin. Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study. Annals of Epidemiology 2014; 24(11): 817 doi: 10.1016/j.annepidem.2014.08.004
|
| 9 |
Po-An Hu, Sz-Han Wang, Chia-Hui Chen, Bei-Chia Guo, Jenq-Wen Huang, Tzong-Shyuan Lee. New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation. Nutrients 2022; 14(11): 2329 doi: 10.3390/nu14112329
|
| 10 |
A. Russolillo, S. Iervolino, R. Peluso, R. Lupoli, A. Di Minno, N. Pappone, M. N. D. Di Minno. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology 2013; 52(1): 62 doi: 10.1093/rheumatology/kes242
|
| 11 |
M.N.D. Di Minno, A. Tufano, A. Guida, M. Di Capua, A.M. De Gregorio, A.M. Cerbone, G. Tarantino, G. Di Minno. Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thrombosis Research 2011; 127(3): 193 doi: 10.1016/j.thromres.2010.12.005
|
| 12 |
Vânia M. Morelli, Renée de Mutsert, Albert de Roos, Hildo J. Lamb, Astrid van Hylckama Vlieg, Mettine H.A. Bos, Frits R. Rosendaal, Willem M. Lijfering, Suzanne C. Cannegieter. Association Between Hepatic Triglyceride Content and Coagulation Factors. Arteriosclerosis, Thrombosis, and Vascular Biology 2020; 40(12): 3004 doi: 10.1161/ATVBAHA.120.315365
|
| 13 |
飏 屈. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Clinical Evidence and a Mechanistic Review. Advances in Clinical Medicine 2023; 13(08): 12753 doi: 10.12677/ACM.2023.1381788
|
| 14 |
Dongyang Chen, Qiangqiang Li, Zhen Rong, Yao Yao, Zhihong Xu, Dongquan Shi, Qing Jiang. Incidence and risk factors of deep venous thrombosis following arthroscopic posterior cruciate ligament reconstruction. Medicine 2017; 96(22): e7074 doi: 10.1097/MD.0000000000007074
|
| 15 |
Abdel-Rauf Zeina, Yael Kopelman, Amir Mari, Helal Said Ahmad, Suheil Artul, Ali Sleman Khalaila, Randa Taher, Fernando Zertuche Villannueva, Rabea Safadi, Saif Abu Mouch, Fadi Abu Baker. Pulmonary embolism risk in hospitalized patients with nonalcoholic fatty liver disease: A case-control study. Medicine 2022; 101(45): e31710 doi: 10.1097/MD.0000000000031710
|
| 16 |
Nurcan KAÇMAZ KAT, Nur Ozer SENSOY, Mustafa KUZEYTEMİZ, Ömer Furkan DEMİR. Prognostic value of non-alcoholic fatty liver disease in patients with pulmonary embolism. The European Research Journal 2024; 10(1): 97 doi: 10.18621/eurj.1353100
|
| 17 |
A. TRIPODI, Q.M. ANSTEE, K.K. SOGAARD, M. PRIMIGNANI, D.C. VALLA. Hypercoagulability in cirrhosis: causes and consequences. Journal of Thrombosis and Haemostasis 2011; 9(9): 1713 doi: 10.1111/j.1538-7836.2011.04429.x
|
| 18 |
MATTEO NICOLA DARIO Di MINNO, SALVATORE IERVOLINO, ROSARIO PELUSO, ANNA RUSSOLILLO, ROBERTA LUPOLI, RAFFAELE SCARPA, GIOVANNI Di MINNO, GIOVANNI TARANTINO. Hepatic Steatosis and Disease Activity in Subjects with Psoriatic Arthritis Receiving Tumor Necrosis Factor-α Blockers. The Journal of Rheumatology 2012; 39(5): 1042 doi: 10.3899/jrheum.111391
|
| 19 |
Alexandra Jichitu, Simona Bungau, Ana Maria Alexandra Stanescu, Cosmin Mihai Vesa, Mirela Marioara Toma, Cristiana Bustea, Stela Iurciuc, Marius Rus, Nicolae Bacalbasa, Camelia Cristina Diaconu. Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. Diagnostics 2021; 11(4): 689 doi: 10.3390/diagnostics11040689
|
| 20 |
Xuerong Wen, Shuang Wang, Tracey H. Taveira, Fatemeh Akhlaghi, Tomohiko Ai. Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH). PLOS ONE 2021; 16(9): e0251665 doi: 10.1371/journal.pone.0251665
|
| 21 |
SALVATORE IERVOLINO, MATTEO NICOLA DARIO DI MINNO, ROSARIO PELUSO, MARIANA LOFRANO, ANNA RUSSOLILLO, GIOVANNI DI MINNO, RAFFAELE SCARPA. Predictors of Early Minimal Disease Activity in Patients with Psoriatic Arthritis Treated with Tumor Necrosis Factor-α Blockers. The Journal of Rheumatology 2012; 39(3): 568 doi: 10.3899/jrheum.110763
|
| 22 |
Chang-Yeon Kim, Namkyun Kim, Jae-Hyung Roh. Association of nonalcoholic fatty liver disease and venous thromboembolic disease in healthy adults in Korea: a nationwide study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42963-9
|
| 23 |
Armando Tripodi, Anna L. Fracanzani, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Pier Mannuccio Mannucci, Flora Peyvandi, Cristina Bertelli, Luca Valenti, Silvia Fargion. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2014; 61(1): 148 doi: 10.1016/j.jhep.2014.03.013
|
| 24 |
Jonathan G. Stine, Blake A. Niccum, Alex N. Zimmet, Nicolas Intagliata, Stephen H. Caldwell, Curtis K. Argo, Patrick G. Northup. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clinical and Translational Gastroenterology 2018; 9(3): e140 doi: 10.1038/s41424-018-0002-y
|
| 25 |
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. Clinical and Molecular Hepatology 2023; 30(1): 16 doi: 10.3350/cmh.2023.0315
|
| 26 |
Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter. Sex‐specific aspects of venous thromboembolism: What is new and what is next?. Research and Practice in Thrombosis and Haemostasis 2022; 6(4): e12722 doi: 10.1002/rth2.12722
|
| 27 |
Jason Yerke, Seth R. Bauer, Stephanie Bass, Heather Torbic, Michael Militello, Erin Roach, Ibrahim Hanouneh, Sarah Welch. Effectiveness of venous thromboembolism prophylaxis in patients with liver disease. World Journal of Hepatology 2019; 11(4): 379-390 doi: 10.4254/wjh.v11.i4.379
|
| 28 |
Jonathan G. Stine, Patrick G. Northup. Coagulopathy Before and After Liver Transplantation. Clinics in Liver Disease 2017; 21(2): 253 doi: 10.1016/j.cld.2016.12.003
|
| 29 |
William Hinton, Banne Nemeth, Simon de Lusignan, Ben Field, Michael D. Feher, Neil Munro, Lara N. Roberts, Roopen Arya, Martin B. Whyte. Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism. Diabetic Medicine 2021; 38(5) doi: 10.1111/dme.14452
|
| 30 |
Quentin Maestraggi, Mohamed Bouattour, Ségolène Toquet, Roland Jaussaud, Reza Kianmanesh, François Durand, Amélie Servettaz. Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia. Medicine 2015; 94(46): e1966 doi: 10.1097/MD.0000000000001966
|
| 31 |
Jonathan G. Stine, Nicolas Intagliata, Patrick G. Northup, Stephen H. Caldwell. Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation. Transplantation 2017; 101(8): e281 doi: 10.1097/TP.0000000000001807
|
| 32 |
Greg C.G. Hugenholtz, Patrick G. Northup, Robert J. Porte, Ton Lisman. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?. Blood Reviews 2015; 29(2): 127 doi: 10.1016/j.blre.2014.10.002
|
| 33 |
E Pardina, R Ferrer, J Rossell, D Ricart-Jané, K A Méndez-Lara, J A Baena-Fustegueras, A Lecube, J Julve, J Peinado-Onsurbe. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery. International Journal of Obesity 2017; 41(9): 1388 doi: 10.1038/ijo.2017.115
|
| 34 |
Alexander J. Kovalic, Sanjaya K. Satapathy. The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes. Clinics in Liver Disease 2018; 22(1): 141 doi: 10.1016/j.cld.2017.08.011
|
| 35 |
Stefano Ballestri, Mariano Capitelli, Maria Cristina Fontana, Dimitriy Arioli, Elisa Romagnoli, Catia Graziosi, Amedeo Lonardo, Marco Marietta, Francesco Dentali, Giorgio Cioni. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Advances in Therapy 2020; 37(5): 1910 doi: 10.1007/s12325-020-01307-z
|
| 36 |
Filipe Nery, Dominique Valla. Splanchnic and Extrasplanchnic Thrombosis in Cirrhosis: Prophylaxis vs Treatment. Current Hepatology Reports 2014; 13(3): 224 doi: 10.1007/s11901-014-0233-7
|
| 37 |
M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M. de Vos, G.M. Dallinga-Thie, M. Levi, E.S. Stroes, M. Nieuwdorp. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?. Clinical Microbiology and Infection 2013; 19(4): 331 doi: 10.1111/1469-0691.12170
|
| 38 |
Armando Tripodi, Rosa Lombardi, Massimo Primignani, Vincenzo La Mura, Flora Peyvandi, Anna L. Fracanzani. Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. Biomedicines 2022; 10(2): 249 doi: 10.3390/biomedicines10020249
|
| 39 |
Wilma Potze, Mohammad S. Siddiqui, Sherry L. Boyett, Jelle Adelmeijer, Kalyani Daita, Arun J. Sanyal, Ton Lisman. Preserved hemostatic status in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2016; 65(5): 980 doi: 10.1016/j.jhep.2016.06.001
|
| 40 |
Marta Bellesini, Matteo Bianchin, Chiara Corradi, Marco Paolo Donadini, Emanuel Raschi, Alessandro Squizzato. Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review. Clinical Drug Investigation 2020; 40(11): 1001 doi: 10.1007/s40261-020-00962-y
|
| 41 |
Peter Lykke Eriksen, Karen Louise Thomsen, Michael Sørensen, Hendrik Vilstrup, Anne-Mette Hvas. Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. Thrombosis Research 2022; 213: 9 doi: 10.1016/j.thromres.2022.02.023
|
| 42 |
Roberta Forlano, Benjamin H. Mullish, Rooshi Nathwani , Ameet Dhar, Mark R. Thursz, Pinelopi Manousou . Non-Alcoholic Fatty Liver Disease and Vascular Disease. Current Vascular Pharmacology 2020; 19(3): 269 doi: 10.2174/1570161118666200318103001
|
| 43 |
Anil J. Trindade, Tany Thaniyavarn, Nikroo Hashemi, Antonio Coppolino, John C. Kennedy, Hari R. Mallidi, Souheil El-Chemaly, Hilary J. Goldberg. 1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease. ERJ Open Research 2021; 7(3): 00103-2021 doi: 10.1183/23120541.00103-2021
|
| 44 |
Amandeep Singh, Aly ElBoraie, Nan Lan, Mohit Gupta. Factors Associated with Deep Vein Thrombosis in Type 2 Diabetics with Biopsy-Proven Non-alcoholic Fatty Liver Disease. SN Comprehensive Clinical Medicine 2020; 2(1): 32 doi: 10.1007/s42399-019-00188-w
|
| 45 |
Alessandro Ciavarella, Davide Gnocchi, Carlo Custodero, Gennaro Mariano Lenato, Giorgio Fiore, Carlo Sabbà, Antonio Mazzocca. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thrombosis Research 2021; 198: 139 doi: 10.1016/j.thromres.2020.12.002
|
| 46 |
Matteo Nicola Dario Di Minno, Antonella Tufano, Walter Ageno, Paolo Prandoni, Giovanni Di Minno. Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Internal and Emergency Medicine 2012; 7(1): 9 doi: 10.1007/s11739-011-0582-y
|
| 47 |
|